Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISTOP prospective biomarker and preventive antiepileptic treatment study in infants with tuberous sclerosis complex
NL-OMON41140Active, not recruiting
- Sponsor
- Children's Memorial Health Institute
- Start
- Dec 2014
- Countries
- 1
01
Overview
Randomised, open-label trial in epilepsy (3 arms), sponsored by Children's Memorial Health Institute. Primary endpoint: Primary biomarker assessment. Started Dec 2014; status: active, not recruiting.
02
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON41140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41140.